Search
for
Sort by
Research 31–60 of 61
- Bioavailability File: Bicalutamide
- Subject Index
- Psychodermatology
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- The Nutrient–Skin Connection: Diagnosing Eating Disorders Through Dermatologic Signs
- Hypersensitivity to intravenous ondansetron: a case report
- Breast cancer in a transgender man
- The Rotterdam Study: objectives and design update
- The Rotterdam Study: 2010 objectives and design update
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Research progress on the natural products in the intervention of myocardial infarction
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Alopecia secondary to severe discoid lupus responding to anifrolumab
- Short- and mid-term outcomes of multisystem inflammatory syndrome in children: a longitudinal prospective single-center cohort study
- Evaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients
- Phenol in dermatology: updated evidence on efficacy and safety
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- A Nano-Pharmaceutical Formula of Quercetin Protects from Cardiovascular Complications Associated with Metabolic Syndrome
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Blockbuster Weight-Loss Drugs Not Tied to Suicidality, Studies Show
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- A Comprehensive Review of Acne Treatments: Unpacking the Chemical Structures and Effective Bioactive Compounds